MedPath

The Effect of Alpha Linolenic Acid Intake on Patients With Elevated Glycemic Status

Not Applicable
Conditions
Elevated Blood Sugar
Interventions
Dietary Supplement: Flaxseed oil capsule
Dietary Supplement: Corn oil capsule
Registration Number
NCT05053347
Lead Sponsor
Huazhong University of Science and Technology
Brief Summary

The findings of previous experiments suggested that alpha linolenic acid (ALA) has been linked to anti-hyperglycemic, and reducing the risk of diabetes.This is a randomized double-blind cross-over trial, aims to study the effect of ALA on glycemic status and human metabolism. Firstly, the investigators will investigate the efficacy of ALA on improving the indexes of glucose metabolism. Secondly, next generation sequencing (NGS), ultra-high performance liquid chromatography-tandem mass spectrometric (UPLC-MS/MS) and gas chromatography-mass spectrometry detection will be conducted to explore the role of ALA on gut microbiota as well as metabolites. Thirdly, single nucleotide polymorphism will be genotyped by Time-of-flight mass spectrometry to find the gene-environment interaction effect.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
128
Inclusion Criteria
  • Fasting blood glucose 6.1-8.4mmol /L;
  • HBA1c 5.7-7.0%;
  • OGTT 2h or postprandial blood glucose 7.8-11.1 mmol/L;
  • Patients with previously diagnosed type 2 diabetes with stable drug hypoglycemic treatment and blood glucose controlled well.
Exclusion Criteria
  • Under 30 years old or over 75 years old;
  • Suffering from severe obesity, thyroid disease, or other serious diseases, such as mental illness;
  • Take nutritional supplements, such as fish oil capsules, Perilla seed oil and flaxseed oil capsules, for nearly one month;
  • Intake more than 20g walnuts per day or more than 100g fatty fish per week in the last month;
  • Daily cooking oil is linseed oil or rapeseed oil and other α -linolenic acid rich vegetable oil;
  • Have been diagnosed with type 2 diabetes and are currently receiving insulin injection;
  • Allergic to the content of intervention;
  • Failure to eat the tested sample as prescribed and affect the efficacy or safety judgment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Flaxseed oilFlaxseed oil capsuleFlaxseed oil capsule, 5g/d(ALA2.5g/d)
Corn oilCorn oil capsuleCorn oil capsule, 5g/d
Primary Outcome Measures
NameTimeMethod
changes of HbA1c0 week,12th week, 20th week and 32th week in the intervention period

glycated hemoglobin

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath